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BY I. LEVIN AND M. J.  SITTENFIELD. 
(From the Department  of Pathology  of Columbia  University,  College of Physi- 
cians  and  Surgeons,  New  York.) 
In  a  previous  communication,  one  of  the  present  writers  (I) 
showed that  the result of tumor implantation  is determined  by two 
factors : first, whether or not the implanted tumor becomes ingrafted, 
and second, the rate of its growth if ingrafted. 
The  mechanism  of  ingrafting  is  common  to  tumor  and  normal 
tissue.  Thus,  Ribbert  (2)  has  successfully implanted  human  skin 
into the ear of the rabbit.  On the other hand, the ultimate fate and 
character  of  the  graft  depends  on  the  rate  of  growth  of  the  im- 
planted tissue. 
If the  growth  of  the  latter  proceeds  at  approximately  the  same 
rate as that of the surrounding  tissue, the implanted tissue develops 
into  a  small  nodule  which  is  ultimately  absorbed.  On  the  other 
hand,  if  the  intensity  of  the  cell  proliferation  in  the  implanted 
tumor  exceeds that  of the  surrounding  tissue,  there  will  develop a 
large malignant tumor.  The rate of growth of an implanted tumor 
and  with  it  the  ultimate  character  of  the  tumor  depend  upon  an 
interaction  between  the  power  of  proliferation  of  the  tumor  cell 
and the resistance  of the host.  The mere grafting  of the tumor  is 
independent  of the phenomenon of cancer immunity. 
A  great  deal of the confusion and  controversy that  exists  in the 
attempted  analysis  of the  results  of the  work on  cancer  immunity 
is caused by this  lack of appreciation of the coexistence of the  two 
factors  determining  the  outcome  of  the  tumor  implantation.  It 
seemed, therefore,  desirable to undertake a  revision of the work on 
cancer immunity. 
* Conducted at  the  expense of the  George Crocker Special Research Fund 
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The most popular  and most generally accepted theory of cancer 
immunity is  the one advanced by Ehrlich and is  commonly desig- 
nated the athrepsia hypothesis.  It is based on the following consid- 
erations :- 
Immunity or  resistance of the host  to  the growth of  an  inocu- 
lable cancer is not specific in its  character, and  an animal immune 
against  carcinoma  will  be  also  immune  against  sarcoma.  The 
methods used to induce an artificial immunization are likewise not 
specific.  When  a  cancer of  low  virulence  is  inoculated  into  and 
absorbed by the host, the latter is  immune in the majority of cases 
against subsequent inoculation of any of the most virulent cancers. 
The  same immunization may also be accomplished by an  inocula- 
tion of normal tissue cells of the same species of animals  or even 
of cells of a  phylogenetically closely related species of animals,  as, 
for instance, with mouse cells in immunization of the rat,  and vice 
versa.  This  non-specific  character  of  cancer  immunity  Ehrlich 
designates by the name of panimmunity. 
According to Ehrlich, as well as to most of the investigators on 
the  subject,  an  artificial  immunity may be  induced  only by treat- 
ment  with  living  cells.  Growth  of  inoculated  cancers  is  due,  of 
course, to cell activity.  ]~hrlich contends that the growth of a can- 
cer indicates that the tumor cells possess a great avidity for a certain 
specific  food  within  the  organism  of  the  host  and  consequently 
obtain  it  from  the  normal  tissue  cells  of  the  organism.  When 
cancer fails to grow, then either the organism of the host does not 
possess the necessary specific food or else the avidity of the cancer 
for this food is not strong enough to deprive the normal tissue cells 
of it.  When the organism of the host is  immunized by treatment 
with a  cell emulsion,  these cells bind  the  specific  food  and  conse- 
quently  the  cancer  cells  inoculated  subsequently  do  not  find  the 
necessary nourishment and die.  Immunity, then, to cancer growth 
consists in the lack of  food athrepsia. 
The experimental evidence adduced by Ehrlich in support of his 
theory consists  in  the  so-called zigzag transplantation,  the second 
inoculation  on  a  tumor-bearing animal  and  the  inoculation  of  an 
emulsion consisting of  a  mixture  of  two  tumors  (carcinoma  and 
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In the present  investigation,  a  separate  detailed  study was made 
of  each  of  the  experimental  proofs  mentioned  above,  and  in  the 
following pages  each  of them  will be considered  separately.  The 
studies  on immunity  in  inoculable  cancer,  of which  this  investiga- 
tion presents one phase, were conducted on white rats only, as these 
animals  are  better  adapted  for  experimentation.  For  the  present 
investigation,  however,  both  rats  and  mice  were  used,  and  in  all 
five  different  tumors  served  for  the  experiment.  Two  of  these 
were  rat  tumors;  an  extremely  virulent  Ehrlich  sarcoma,  and  the 
Flexner-Jobling  carcinoma,  which  is not as virulent  as the  former. 
The  three  mouse  tumors  used  were  Ehrlich's  carcinoma  of  the 
mouse (No. 33), Bashford's carcinoma of the mouse  (No. 27), and 
Ehrlich's  sarcoma  of  the  mouse.  The  last  named  was  the  most 
virulent of the mouse tumors. 
PANIMMUNITY. 
Ehrlich did not consider the phenomenon of panimmunity a direct 
proof of athrepsia,  but there must undoubtedly be a certain relation 
between the general non-specific character of the former and athrep- 
sia,  which  is merely a  phase  in  intracellular  nutrition.  Indeed,  if 
athrepsia  is  to  have  a  general  application  it  must  be  capable  of 
explaining  the  conditions  of  panimmunity  against  the  different 
tumors  used  in  this  research,  and  it  may be stated  that  in  a  gen- 
eral  way the  fact of panimmunity  was  found to be correct  for the 
majority of cases.  But there  were  factors  observed in  the course 
of these experiments which can not be explained on the basis of the 
theory of athrepsia.  Of such experiments  the  following instances 
may be cited. 
Experiment  z.--Twenty-nine  rats  which  had  been  previously  immunized 
against  an  inoculation  of  a  rat  carcinoma  (Flexner-Jobling)  were  inoculated 
four  weeks  later  with  a  rat  sarcoma  (Ehrlich).  Of  these  rats,  twenty-three 
remained  immune  and  only  six,  or  2o per cent.,  of  the inoculated  animals  grew 
the tumor,  while of  twenty control  rats,  17,  or 85 per  cent.,  took the tumor. 
Of these two tumors, the Flexner-Jobling carcinoma grows much 
more  slowly than  the  Ehrlich  rat  sarcoma  and  does  not  reach  as 
large  a  size.  Consequently the  former  tumor has  less  avidity  for 
the  specific  food than  the  sarcoma,  and  does not,  according  to  the 
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cient  amount of specific  food  should  be  left  for  the  subsequently 
inoculated sarcoma cells,  and it should be possible  to inoculate the 
latter successfully in all the treated animals. 
The  following experiment shows again that all the facts of pan- 
immunity can  not be  explained  on  the  basis  of  athrepsia. 
Experiment 2.--Twenty rats were inoculated with  a  mouse sarcoma, and 
four  weeks later, when the grafts  were completely absorbed, they were inocu- 
lated with a rat sarcoma.  Of the fifteen rats which survived at the last examina- 
tion, the tumor grew only in two.  This shows I3 per cent. of takes, while in 
the twenty control animals, the tumor took in 9o per cent. 
It will be  shown later that according to  the theory of athrepsia 
the cells of a mouse tumor are unable to anchor the specific food of 
the  rat.  Consequently the  specific  food needed  for the  success  of 
the inoculation of a  rat sarcoma should exist in the same quantity 
in the  rats  treated with mouse sarcoma as  in  the  control animals. 
Still the rats treated with mouse tissue were immune to the inocula- 
tion of rat  tumor.  The  fact that it  is  possible  to  immunize a  rat 
with mouse tissue, and vice versa, was previously observed by Carl 
Lewin and by one of the present  writers. 
Another  factor observed  in  the  course  of  these  experiments on 
panimmunity, which is  of great importance in the consideration of 
the  significance of  athrepsia,  is  the  following: whenever  a  tumor 
succeeds  in  growing  in  one  of  the  previously treated  animals,  it 
attains the same size and virulence as in the control animals. 
This phenomenon indicates that panimmunity  with its non-specific 
character is in reality an immunity to tissue grafting.  On the other 
hand,  when the  cancer cells  are  ingrafted, such  preliminary treat- 
ment of the animals with living tissue, as is used in experiments on 
panimmunity, does not exert any influence whatever on the subse- 
quent growth or virulence of the developing tumor.  The truth of 
this  assertion  is  also  evident  from the  fact that  no  immunization 
with  living  tissue  is  successful  if  it  is  done  subsequently  to  the 
inoculation of the tumor. 
The  experiments  of  Rous  (3)  with  inoculation  of  embryonic 
tissue show that by the same method an animal may be immunized 
against  the grafting of  embryonic cells.  Here  again  is  apparent 
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reality  an  immunity  against  implantation  of  tissue.  But  since  in 
all  experimental  cancer  work  with  the  inoculable  tumors  the  first 
step always consists in the inoculation of a piece of the tumor, such 
tissue  immunity  obscures  the  actual  immunity  to  the  growth  and 
development  of the  cancer. 
ZIGZAG TRANSPLANTATIONS. 
This  phenomenon,  which  served as  the  main  experimental  basis 
for the formation of the theory of athrepsia,  consists in the  follow- 
ing: When a mouse sarcoma is inoculated into a  rat,  it grows there 
normally  for about  eight  or  ten  days,  then  ceases to  grow  and  is 
absorbed.  But  if  before  absorption  takes  place  the  nodule  is 
removed  from  the  rat  and  transferred  to  a  mouse,  it  continues  to 
grow normally and may be subsequently transferred  to another rat, 
where it will grow for about eight days, and so on. 
Ehrlich  explains  the  result  of these  experiments  by the  supposi- 
tion  that  tumor  cells  in  order to  proliferate  must  obtain  a  certain 
specific food x,  which they can find only in an animal  of the  same 
species as that  from which  the  tumor cells have  come.  Cells  of a 
mouse  tumor  inoculated  into  a  rat  proliferate  for  a  few  days,  as 
long as the  food x, which they brought over from the mouse, lasts. 
When this  is used up, they do not find this  specific food in the rat 
and  cease  to  grow,  but grow again  when  transferred  to  a  mouse, 
where they find again this specific food.  On the basis of this  sup- 
position,  Ehrlich  created  the  general  theory  that  whenever  cancer 
cells  fail to  proliferate,  it  means  that  they  fail  to  obtain  the  food 
x,  either  because  the  normal  body  cells  have  greater  avidity  for 
this  food  than  the  cancer  cells,  or  else  the  cells  with  which  the 
animals  were  immunized  anchored  all  the  specific  food  and  the 
cancer cells inoculated  subsequently could not obtain it. 
The  experiments  of  zigzag  transplantation  were  undertaken  by 
the  writers  on  all  the  tumors  used  in  this  investigation.  In  the 
course of these experiments certain  facts were observed which indi- 
cate that  athrepsia can not account  for all the phenomena  observed 
with zigzag transplantations. 
The  inoculation  of the  rat  sarcoma  and  rat  carcinoma  into mice 
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small nodules in the host of different species.  When these nodules 
were retransferred into animals of the species from which the orig- 
inal  tumors  were  derived,  for  instance,  when  a  rat  sarcoma  was 
retransplanted  from a  mouse into  a  rat,  not  a  single  good tumor 
growth could be  produced  by  any of the  three  tumors mentioned 
above. 
With Ehrlich's mouse sarcoma and Bashford's mouse carcinoma, 
the results of the experiments appeared to be more successful, i. e., 
when a  nodule of the mouse sarcoma or carcinoma, after a  sojourn 
of eight to  ten days in a  rat,  was  removed  and  inoculated into  a 
mouse,  it  grew,  in  a  certain  number  of  cases,  into  a  good  sized 
tumor.  The number of such successful inoculations, however, was 
much smaller than the number of takes in control animals, i.  e., in 
animals that were inoculated with tumor material which was taken 
directly from a  mouse.  The following series of experiments illus- 
trates this point. 
Bashford's Mouse Carcinoma  Inocnlated into 20 Rats; 2, 4, 6, and  8 Days Later 
Nodules  Were  Removed  from  the  Rats  and  Inoculated  into  Mice. 
2 days  4 days  6 days  8 days  Total.  Control. 
later.  [  later  later,  later. 
No.  of mice inoculated  ................  [  io  }  :to  15  io  45  20 
No. of mice surviving  at final examination  8  9  I4  4o  2o 
No.  of mice with  tumors  ..............  4  I  4  IO  18 
,  25  90 
Ehrllch's Mouse  Carcinoma  Inoculated  into  2o Rats; 2,  4,  6,  and 8 Days Later 
Nodules Were Removed from the Rats and Inoculated into  Mice. 
2 days  4 days  6 days  8 days  [ Total.  I  Control. 
later.  I  later,  later,  later. 
No.  of mice inoculated  ................  [  IO  [  IO  IO  7  37  20 
NO. of mice surviving  at final examination]  9  ]  6  io  i  26  I8 
No.  of mice with  tumors  ..............  1  I  ]  2  o  [  I  [  4  z4 
Percent.  of takes ....................  ]  '  [  [  I~-.4  1  77.8 
An  analysis  of  these  experiments  on  zigzag  transplantations 
shows  that  all tumors,  or  at  least  all  the  tumors  with which  this 
investigation was  conducted,  can  be  successfully grafted  on  the 
phylogenetically closely  related  animals,  i.  e.,  from  rat  to  mouse 
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bryonic  tissue.  But  the  ingrafted  cancer  cells  do  not  proliferate 
indefinitely and become malignant in the host of a  foreign species. 
The  explanation  of  this  phenomenon  given  by  Ehrlich  does  not 
seem to be adequate to explain all the factors in connection with it. 
If a  mouse tumor fails to grow in the rat only for lack of specific 
food,  then  it  should  retain  its  normal virulence when transferred 
into a host of its own species.  But experiments show that the viru- 
lence of a  mouse or rat tumor is  so diminished by its  eight to  ten 
days sojourn in a  host of a  different species that it either  fails  to 
take at  all  when reinoculated into  a  host  of its  own species,  or  it 
takes  in  a  very  small  percentage.  It  is  evident  then  that  the 
organism of the temporary host has a decidedly noxious effect upon 
the proliferating activities of the tumor cells, and, moreover, while 
the  capacity  for  ingrafting  in  an  animal  of  a  foreign  species  is 
common to  all the tumors studied  and  is  non-specific, the amount 
of injury sustained through the sojourn in the  foreign host  is dif- 
ferent with the different tumors. 
SECOND  INOCULATION  ON  A  TUMOR-BEARING ANIMAL. 
Ehrlich maintains that  animals on which a successful  inoculation 
of another tumor was previously made  appeared to be immune 
against a subsequent inoculation,  either  of the same or another 
tumor.  The  opposite  results  found by Hertwig  and  Poll (4), 
Gierke  (5),  and Borrel (6),  he explains  by the fact  that  in their 
experiments they used for the primary inoculation  tumors of low 
virulence  and slow growth, while in his experiments  the animals 
received  for  the  first  inoculation  an  extremely  virulent  tumor. 
Only a very virulent, rapidly growing tumor anchors all the specific 
food  x  and  consequently makes the  successful take  of  the  subse- 
quently  inoculated  tumor  impossible.  A  slowly  growing  tumor 
leaves  a  sufficient amount  of  the  specific  food  for the  successful 
take of a subsequent inoculation. 
Experiments with a double inoculation were conducted with the 
Flexner-Jobling  rat  carcinoma  and  with  Ehrlich's  rat  sarcoma. 
The latter is an extremely virulent and rapidly growing tumor, and 
still  a  subsequent  inoculation  of  the  carcinoma  was  just  as  suc- 
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the sarcoma on an animal  with a  growth of carcinoma.  The  most 
plausible explanation of the discrepancies  in similar experiments  of 
different investigators  consists  in the different behavior of the  dif- 
ferent  tumor  cells  after  a  successful grafting.  This  latter  factor 
is most evident in the series of experiments on the inoculation of an 
emulsion  consisting  of two tumors. 
INOCULATION  OF  AN  EMULSION  CONSISTING  OF  TWO  TUMORS. 
Apolant  (7)  inoculated  an  emulsion  of  a  carcinoma  and  sar- 
coma  into  an  animal  and  developed  a  mixed  tumor  showing  the 
structure both of the carcinoma and sarcoma.  If one of the tumors 
was originally more virulent than the other,  or if its virulence was 
increased  artificially,  then  the  resulting  growth  showed  the  struc- 
ture  of the more virulent  tumor only.  Ehrlich  adduces the  results 
of this  experiment as another proof of the  fact that  the more viru- 
lent tumor cells obtain all the specific food of the host,  causing the 
cells of the  weaker tumor to die of starvation. 
These experiments were repeated with two emulsions.  One, con- 
sisting of the cells of the Flexner-Jobling carcinoma and of Ehrlich's 
sarcoma of the  rat,  was  injected  into  rats,  and  another,  consisting 
of Bashford's carcinoma and Ehrlich's  mouse sarcoma, was injected 
into  mice.  In  both  instances  the  sarcoma  was  a  great  deal  more 
virulent than the carcinoma.  The relation in virulence between the 
Flexner-Jobling carcinoma and the Ehrlich  rat sarcoma,  on the one 
hand,  and the Bashford carcinoma and the Ehrlich  mouse sarcoma, 
on the other,  is quite identical,  but a  most surprising difference was 
observed in the results of the two experiments.  While  in the  rats, 
on  the  injection  of  the  emulsion,  there  developed  a  mixed  tumor 
showing  the  structure  both  of carcinoma  and  sarcoma,  the  tumor 
in the mice appeared to be pure sarcoma.  Thus  it  seems that  dif- 
ferent tumors behave in a  different manner  when introduced  simul- 
taneously into an organism. 
Of all  the  experiments  stated  above, the  zigzag  transplantations 
undoubtedly  offer  the  best  field  for  the  analysis  of  the  different 
phenomena  of  immunity  in  cancer.  The  apparent  success  of  an 
inoculation of a  mouse tumor into a  rat may mean only the success 
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munity against  the growth of a  mouse cancer.  Indeed,  the  nodule 
which  develops  in  the  rat  upon  an  inoculation  of  a  mouse  tumor 
never  develops  into  a  large  malignant  growth.  There  is  conse- 
quently a  condition here in which the dual character of the immunity 
to an inoculable tumor is perfectly apparent.  The rat is susceptible 
to the grafting of a  mouse sarcoma,  but immune against  its malig- 
nant  development.  Another proof of these two conditions  in can- 
cer immunity is shown in the influence of pregnancy on inoculations 
of a tumor.  Haaland  (8)  found that an inoculable tumor does not 
take well on a  gravid animal,  and  Ehrlich  explains  this  fact on the 
supposition that  during pregnancy all the available food is used up 
by the body cells.  Herzog  (9)  has shown, on the other hand,  that 
when a  tumor-bearing  animal  becomes pregnant  the tumor appears 
to grow  faster.  In  other  words,  pregnancy  produces  a  resistance 
against the grafting of tumor cells, while it enhances  the prolifera- 
tion of the tumor cells present in the organism. 
The  success of the  grafting  of  the  inoculated  cells  undoubtedly 
depends upon conditions  of nutrition.  Thus,  athrepsia  may serve 
to  explain  the  conditions  of  resistance  and  susceptibility  to  the 
grafting  of  tumor  as  well as  tissue  cells.  The  formation  of  a 
highly vascularized stroma around  the successfully ingrafted  tissue 
and the lack of stroma  formation in an unsuccessful graft  (Russell 
(Io))  also shows the  importance  of nutrition  during  this phase of 
the inoculation of a tumor. 
On the other hand,  the same experiments  on zigzag  transplanta- 
tions  clearly  indicate  that  differences  in  nutrition  can  not  explain 
the  reason  why in  one  successful tumor  graft  a  small  nodule  will 
form  which  is  subsequently absorbed,  while  in  another  the  nodule 
will grow into a large tumor and kilt the animal. 
As stated above, this  investigation  has  shown that  a  lack of spe- 
cific  food alone  can  not explain  the  failure  of a  mouse  carcinoma 
or  sarcoma  to  develop  into  a  malignant  tumor  in  the  rat.  The 
organism  of  the  rat  has  a  direct  influence  upon  the  mouse  tumor 
and  its  virulence  is  greatly  diminished  after  a  sojourn  of  a  few 
days in  this  animal.  The  organism  of the  rat  has  consequently a 
noxious  effect upon  the  proliferating  activities  of  the  cells  of  the 
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upon an inoculation of these weakened cells into another generation 
of mice,  the  normal virulence of the  former returns.  The  follow- 
ing series of experiments illustrates this point. 
Experiment  3.--Twenty  mice  were  inoculated  with  pieces  of  the  Ehrlich 
mouse  sarcoma  taken  from rats.  Nineteen  mice  survived  at  the  last  examina- 
tion,  and  of these,  one  took the  tumor,  which  represents  5 per  cent.  of takes. 
The tumor from this  mouse was inoculated  in twenty other mice and the tumor 
took in  fourteen, or 7o per cent. 
It  appears  from these  experiments  that  a  mouse  tumor  through 
a  sojourn in the  rat  reacquires  the  characteristics  of a  spontaneous 
tumor; namely, it takes in a  small percentage of inoculated animals, 
and  this  percentage  increases  in  subsequent  generations.  But  the 
diminution  of the  virulence of the tumor  which  takes  place  in  the 
organism  of  th~  rat  is  due  to  congenital  racial  immunity  of  the 
latter.  Furthermore, the immunity of the rat against mouse tumor 
is not due to conditions of nutrition, but is accompanied by an active 
noxious  influence of the  organism  of the  rat  on the mouse tumor. 
Thus  indirect evidence is brought  forward  through  this  investiga- 
tion  to  show  that  immunity  to  cancer  growth,  but  not  to  tumor 
grafting,  is caused  not by differences in intracellular  nutrition,  but 
by  an  active  inhibitory  influence  of  the  organism  of  the  host  on 
the cancer cells.  The search for direct evidence and the true nature 
of this  inhibitory influence is  the  aim  of further studies  on immu- 
nity  in cancer of the white rat. 
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